Recall Prompts DePuy Lawsuits As Published on the DePuy Hip Replacement Website

ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System have been recalled by DePuy which prompted a surge of lawsuits. DePuy was issued a warning by the US Food and Drug Administration after it marketed two hip-replacement systems for unapproved uses. This incident prompted three US Senators to spearhead legislation authorizing the FDA to monitor artificial device manufacturers and implantation recipients. Johnson & Johnson and DePuy announced that the recall was due to necessary revision surgeries after five years from the implantation because of design defects.

These revision surgeries caused worry to overtake patients who received these synthetic ball and socket devices. An overwhelming number of patients with complete hip replacements need a second operation after a five-year period, as Johnson & Johnson researchers found out. Metallosis, a medical condition produces when metal shavings from the implanted device fall to the person’s bloodstream which results in toxicity, have been a usual complaint of patients.

Court filings reveal that DePuy generated an income of U.S.$5.4 billion in sales. Johnson & Johnson’s shares have fallen to nearly 8.5 percent in the New York Stock Exchange. In just two years, the company has recalled more than 50 products. DePuy encouraged the ASR device recipients to consult with their surgeon to assess the implants after the surgery. DePuy also volunteered to cover costs for monitory and treatment services including revision surgeries after the recall.

DePuy employed the services of Broadspire Services Inc. to manage workmen’s compensation and medical claims, including patient’s out-of-pocket medical costs in response to the surge of lawsuits. DePuy included co-pays, deductible expenses, lost wages and travel costs as out-of-pocket costs. All claims will be evaluated on a case-to-case basis by Broadspire Services from insurance companies, employers or patients. DePuy noted 93,000 implantations of their synthetic device on a worldwide scale. Therefore, numerous patients will need new expensive and painful operation to remedy the repercussions of the failing device.

A lot of implant recipients wanting to file aDepuy lawsuit are incited to claim compensation due to the terrible stress it has caused them. More than expected, a higher rate of patients complained of pain, swelling, joint dislocation, and damage to the central nervous system, thyroid and heart. These incidents paved way to 2,000 lawsuits in state and federal courts. To say the least, revision surgeries became a necessary recourse rather than an option. Indeed, the inconvenience and damage warrants a DePuy lawsuit.